According to this study, the global Heart-on-a-chip market size will reach US$ million by 2030.
By "Heart-on-a-chip" technology - simulating the human heart on an engineering chip and using microelectrodes to measure the effects of compound exposure, it is possible to ensure that potential life-saving new drugs are safe and effective, while reducing the need for humans and animal testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Heart-on-a-chip market by product type, application, key players and key regions and countries.
Segmentation by product type:
Children Heart-on-a-chip
Adult Heart-on-a-chip
Segmentation by Application:
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Other End Users
This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Emulate
Tissuse
Hesperos
CN Bio Innovations
Draper Laboratory
Mimetas
Nortis
Kirkstall
Cherry Biotech SAS
Else Else Kooi Laboratory
Micronit Microtechnologies B.V.
Tara Biosystems
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Âé¶¹Ô´´ Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Âé¶¹Ô´´ Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Âé¶¹Ô´´ Overview
2.1.1 Global Heart-on-a-chip Âé¶¹Ô´´ Size 2024-2030
2.1.2 Heart-on-a-chip Âé¶¹Ô´´ Size CAGR by Region
2.2 Heart-on-a-chip Segment by Type
2.2.1 Children Heart-on-a-chip
2.2.2 Adult Heart-on-a-chip
2.3 Heart-on-a-chip Âé¶¹Ô´´ Size by Type
2.3.1 Global Heart-on-a-chip Âé¶¹Ô´´ Size Âé¶¹Ô´´ Share by Type (2024-2030)
2.3.2 Global Heart-on-a-chip Âé¶¹Ô´´ Size Growth Rate by Type (2024-2030)
2.4 Heart-on-a-chip Segment by Application
2.4.1 Pharmaceutical & Biotechnology Companies
2.4.2 Academic & Research Institutes
2.4.3 Other End Users
2.5 Heart-on-a-chip Âé¶¹Ô´´ Size by Application
2.5.1 Global Heart-on-a-chip Âé¶¹Ô´´ Size Âé¶¹Ô´´ Share by Application (2024-2030)
2.5.2 Global Heart-on-a-chip Âé¶¹Ô´´ Size Growth Rate by Application (2024-2030)
3 Heart-on-a-chip Key Players
3.1 Date of Key Players Enter into Heart-on-a-chip
3.2 Key Players Heart-on-a-chip Product Offered
3.3 Key Players Heart-on-a-chip Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players Heart-on-a-chip Valuation & Âé¶¹Ô´´ Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Âé¶¹Ô´´ Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 Heart-on-a-chip by Regions
4.1 Heart-on-a-chip Âé¶¹Ô´´ Size by Regions (2024-2030)
4.2 United States Heart-on-a-chip Âé¶¹Ô´´ Size Growth (2024-2030)
4.3 China Heart-on-a-chip Âé¶¹Ô´´ Size Growth (2024-2030)
4.4 Europe Heart-on-a-chip Âé¶¹Ô´´ Size Growth (2024-2030)
4.5 Rest of World Heart-on-a-chip Âé¶¹Ô´´ Size Growth (2024-2030)
5 United States
5.1 United States Heart-on-a-chip Âé¶¹Ô´´ Size by Type (2024-2030)
5.2 United States Heart-on-a-chip Âé¶¹Ô´´ Size by Application (2024-2030)
6 Europe
6.1 Europe Heart-on-a-chip Âé¶¹Ô´´ Size by Type (2024-2030)
6.2 Europe Heart-on-a-chip Âé¶¹Ô´´ Size by Application (2024-2030)
7 China
7.1 China Heart-on-a-chip Âé¶¹Ô´´ Size by Type (2024-2030)
7.2 China Heart-on-a-chip Âé¶¹Ô´´ Size by Application (2024-2030)
8 Rest of World
8.1 Rest of World Heart-on-a-chip Âé¶¹Ô´´ Size by Type (2024-2030)
8.2 Rest of World Heart-on-a-chip Âé¶¹Ô´´ Size by Application (2024-2030)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
9 Âé¶¹Ô´´ Drivers, Challenges and Trends
9.1 Âé¶¹Ô´´ Drivers & Growth Opportunities
9.2 Âé¶¹Ô´´ Challenges & Risks
9.3 Industry Trends
10 Key Investors in Heart-on-a-chip
10.1 Company A
10.1.1 Company A Company Details
10.1.2 Company Description
10.1.3 Companies Invested by Company A
10.1.4 Company A Key Development and Âé¶¹Ô´´ Layout
10.2 Company B
10.2.1 Company B Company Details
10.2.2 Company Description
10.2.3 Companies Invested by Company B
10.2.4 Company B Key Development and Âé¶¹Ô´´ Layout
10.3 Company C
10.3.1 Company C Company Details
10.3.2 Company Description
10.3.3 Companies Invested by Company C
10.3.4 Company C Key Development and Âé¶¹Ô´´ Layout
10.4 Company D
10.5 ……
11 Key Players Analysis
11.1 Emulate
11.1.1 Emulate Company Details
11.1.2 Emulate Heart-on-a-chip Product Offered
11.1.3 Emulate Heart-on-a-chip Âé¶¹Ô´´ Size (2024 VS 2030)
11.1.4 Emulate Main Business Overview
11.1.5 Emulate News
11.2 Tissuse
11.2.1 Tissuse Company Details
11.2.2 Tissuse Heart-on-a-chip Product Offered
11.2.3 Tissuse Heart-on-a-chip Âé¶¹Ô´´ Size (2024 VS 2030)
11.2.4 Tissuse Main Business Overview
11.2.5 Tissuse News
11.3 Hesperos
11.3.1 Hesperos Company Details
11.3.2 Hesperos Heart-on-a-chip Product Offered
11.3.3 Hesperos Heart-on-a-chip Âé¶¹Ô´´ Size (2024 VS 2030)
11.3.4 Hesperos Main Business Overview
11.3.5 Hesperos News
11.4 CN Bio Innovations
11.4.1 CN Bio Innovations Company Details
11.4.2 CN Bio Innovations Heart-on-a-chip Product Offered
11.4.3 CN Bio Innovations Heart-on-a-chip Âé¶¹Ô´´ Size (2024 VS 2030)
11.4.4 CN Bio Innovations Main Business Overview
11.4.5 CN Bio Innovations News
11.5 Draper Laboratory
11.5.1 Draper Laboratory Company Details
11.5.2 Draper Laboratory Heart-on-a-chip Product Offered
11.5.3 Draper Laboratory Heart-on-a-chip Âé¶¹Ô´´ Size (2024 VS 2030)
11.5.4 Draper Laboratory Main Business Overview
11.5.5 Draper Laboratory News
11.6 Mimetas
11.6.1 Mimetas Company Details
11.6.2 Mimetas Heart-on-a-chip Product Offered
11.6.3 Mimetas Heart-on-a-chip Âé¶¹Ô´´ Size (2024 VS 2030)
11.6.4 Mimetas Main Business Overview
11.6.5 Mimetas News
11.7 Nortis
11.7.1 Nortis Company Details
11.7.2 Nortis Heart-on-a-chip Product Offered
11.7.3 Nortis Heart-on-a-chip Âé¶¹Ô´´ Size (2024 VS 2030)
11.7.4 Nortis Main Business Overview
11.7.5 Nortis News
11.8 Kirkstall
11.8.1 Kirkstall Company Details
11.8.2 Kirkstall Heart-on-a-chip Product Offered
11.8.3 Kirkstall Heart-on-a-chip Âé¶¹Ô´´ Size (2024 VS 2030)
11.8.4 Kirkstall Main Business Overview
11.8.5 Kirkstall News
11.9 Cherry Biotech SAS
11.9.1 Cherry Biotech SAS Company Details
11.9.2 Cherry Biotech SAS Heart-on-a-chip Product Offered
11.9.3 Cherry Biotech SAS Heart-on-a-chip Âé¶¹Ô´´ Size (2024 VS 2030)
11.9.4 Cherry Biotech SAS Main Business Overview
11.9.5 Cherry Biotech SAS News
11.10 Else Else Kooi Laboratory
11.10.1 Else Else Kooi Laboratory Company Details
11.10.2 Else Else Kooi Laboratory Heart-on-a-chip Product Offered
11.10.3 Else Else Kooi Laboratory Heart-on-a-chip Âé¶¹Ô´´ Size (2024 VS 2030)
11.10.4 Else Else Kooi Laboratory Main Business Overview
11.10.5 Else Else Kooi Laboratory News
11.11 Micronit Microtechnologies B.V.
11.12 Tara Biosystems
12 Research Findings and Conclusion
Ìý
Ìý
*If Applicable.